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Abstract Hippocampal volumetric measures may be useful
for Alzheimer’s disease (AD) diagnosis and disease tracking;
however, manual segmentation of the hippocampus is labour-
intensive. Therefore, automated techniques are necessary for
large studies and to make hippocampal measures feasible for
clinical use. As large studies and clinical centres are moving
from using 1.5 Tesla (T) scanners to higher field strengths it is
important to assess whether specific image processing tech-
niques can be used at these field strengths. This study investi-
gated whether an automated hippocampal segmentation tech-
nique (HMAPS: hippocampal multi-atlas propagation and seg-
mentation) and volume change measures (BSI: boundary shift
integral) were as accurate at 3T as at 1.5T. Eighteen
Alzheimer’s disease patients and 18 controls with 1.5T and
3T scans at baseline and 12-month follow-up were used from
the Alzheimer’s Disease Neuroimaging Initiative cohort. Base-
line scans were segmented manually and using HMAPS and
their similarity was measured by the Jaccard index. BSIs were
calculated for serial image pairs. We calculated pair-wise dif-
ferences between manual and HMAPS rates at 1.5Tand 3Tand
compared the SD of these differences at each field strength. The
difference in mean Jaccards (manual and HMAPS) between
1.5T and 3T was small with narrow confidence intervals (CIs)
and did not appear to be segmentor dependent. The SDs of the
difference between volumes from manual and automated seg-
mentations were similar at 1.5Tand 3T, with a relatively narrow
CI for their ratios. The SDs of the difference between BSIs
from manual and automated segmentations were also similar at
1.5T and 3T but with a wider CI for their ratios. This study
supports the use of our automated hippocampal voluming
methods, developed using 1.5T images, with 3T images.
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The hippocampus is one of the earliest site of pathological
changes (Braak and Braak 1991) and atrophy (Jack et al.
1999; Ridha et al. 2006) in Alzheimer’s disease (AD).
Magnetic resonance imaging (MRI) based measurement of
volume and volume change in the hippocampus may be
useful markers for AD diagnosis and tracking progression
(Dubois et al. 2010; Henneman et al. 2009; Jack et al. 2005,
2008b; Wang et al. 2009). However, the “gold standard”
measurement technique of manual segmentation is very
labour intensive, taking up to 45 min per side, and is im-
practical for large studies or clinical trials, making the use of
automated segmentation techniques necessary. Hippocam-
pal Multi-atlas Propagation and Segmentation (HMAPS)
(Leung et al. 2010a) is a template-based automated hippo-
campal segmentation technique that uses a library of hippo-
campal regions that were segmented on a set of 1.5 Tesla (T)
MR scans. HMAPS has been shown to be accurate on 1.5T
scans, but using the same template library on scans acquired
at a different field strength may yield different results.
Despite higher field strengths having the benefit of an im-
proved signal to noise ratio, artefacts such as susceptibility
and chemical shift can bemore apparent andmore important
at higher field strengths (Bernstein et al. 2006; Farahani
et al. 1990; Parizel et al. 1994). Additionally, measurement
of volumes of different brain areas may be affected by
changes in field strength. For example, Kruggel et al
(2010) showed that grey matter and white matter volumes
calculated from a tissue classification algorithm can vary
within subject across different field strengths. Also, prelim-
inary results from Chow et al (2013) suggest that 3T images
may be able to detect volume differences that are not appar-
ent at 1.5T. In contrast, others have found no significant
differences between manually segmented regions (hippo-
campus and amygdala) on 1.5T and 3T images (Briellmann
et al. 2001; Scorzin et al. 2008) and Ho et al (2010) found
that sample size estimates for detecting a slowing of mild
cognitive impairment using Tensor Based Morphology did
not differ between 1.5T and 3T scans.
Furthermore, automated atrophy rate measurements that
rely on measuring intensities within the scan, such as the
boundary shift integral (BSI), may also be affected by
changes in field strength due to an increase in contrast to
noise ratio (Hart et al. 1983). Because higher field strengths
are becoming more commonly used clinically and in thera-
peutic trials, it is important to ensure that automated mea-
sures such as HMAPS are generalisable to higher field
strengths. The aim of this report was to investigate whether
HMAPS is as accurate on 3T scans as on 1.5T scans and
whether volume change estimated using BSI combined with
these automated segmentations was similar using 1.5T and
3T serial image pairs. We also investigated the ability of
HMAPS volumes and atrophy rates to distinguish between
control subjects and subjects with AD and whether the
predictive ability differed between 1.5T and 3T scans.
Methods
Subjects and Scans
Subjects included were AD subjects and controls from the
Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort
who had a 1.5T and 3T scan at both baseline and 12 months.
There were 28 AD and 50 control subjects meeting these
criteria. ADNI is a multi-centre public/private funded longi-
tudinal study investigating adult subjects with AD, amnestic
MCI, and normal cognition. Participants underwent baseline
and periodic clinical and neuropsychometric assessments and
serial MRI. Details are available at http://www.adni-info.org.
Written informed consent was obtained, as approved by the
Institutional ReviewBoard at each of the participating centres.
ADNI inclusion and exclusion criteria are detailed elsewhere
(http://www.adni-info.org/Scientists/Pdfs/ADNI_Protocol_
Extension_A2_091908.pdf).
All scans were downloaded from http://www.loni.ucla.edu/
ADNI. These scans were pre-processed by the ADNI re-
searchers. The ADNI T1 images were corrected for distortion
due to gradient non-linearity (Jovicich et al. 2006) (using N3
(Sled et al. 1998) for all images and B1 (Narayana et al. 1988)
where required), and scaling-corrected based on phantom
measures (Jack et al. 2008a).
For the ADNI study, 1.5T scans and 3T scans of the
same time-point were not always conducted on the same
day and therefore the scan intervals sometimes differed
for 1.5T and 3T scans pairs. Because differences in scan
intervals may have implications for measurement error,
we minimised this effect by excluding potential subjects
with scan interval differences of more than 60 days be-
tween 1.5T and 3T scan pairs. We excluded three AD and
six control subjects that had scan interval differences of
more than 60 days. Scan pairs were visually assessed and
subjects with poor quality scan pairs were excluded in this
study. There were 18 remaining AD subjects and 26
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control subjects with good quality scan pairs. We selected
18 of the good quality control subjects to give equal
numbers of AD and control subjects.
As part of the manual segmentation protocol, we rig-
idly registered the 1.5T scans to the MNI305 atlas. In
order to allow the direct comparison of the segmentations
between 1.5T and 3T scans, we rigidly registered the 3T
scans to the resliced 1.5T scans in the MNI305 space. The
left hippocampus of all baseline scans (1.5T and 3T) was
segmented automatically using HMAPS and manually by
two trained segmentors (segmentor 1 (S1) and segmentor
2 (S2)) independently using an adapted version of a
protocol originally described by Watson et al. (1992)
(see appendix for details of the manual protocol). The
segmentors were blinded to field strength and patient
diagnosis, and neither segmented any of the hippocampi
in the template library.
Prior to calculating the BSI, scan pairs underwent
differential bias correction (DBC) to correct for inhomo-
geneity differences between the scan pairs (Lewis and
Fox 2004). The DBC was performed because varying
amounts of intensity inhomogeneity were still present in
the pre-processed scans after N3 correction. Because
BSI directly compares the intensity between the baseline
and repeat images, DBC is applied to correct the bias
between the two images to improve its robustness to the
intensity inhomogeneity artifacts. The baseline regions
were used to calculate atrophy rates using the BSI with
a double window approach, in order to capture changes
across both the CSF-hippocampal border and the white
matter-hippocampal border (Leung et al. 2010a, b). This
provided an automated HMAPS-BSI measure at 1.5T
and 3T and a corresponding semi-automated atrophy
rate measure S1-BSI and S2-BSI for each manual
segmentor.
Statistics
We used the Jaccard index as a measure of similarity,
which is defined as the magnitude of the intersection
divided by the magnitude of the union of two regions.
Jaccard indices were calculated for the baseline segmen-
tations to assess the accuracy of the HMAPS volumes. We
calculated the pair-wise difference between the Jaccard of
S1 and HMAPS at 1.5T and the Jaccard of S1 and
HMAPS at 3T. A one sample t-test was used to assess
whether the mean of these differences was significantly
different to zero, which would indicate systematically
better agreement with manual for 1.5T compared to 3T
(or vice-versa). Pair-wise differences were also calculated
and assessed in the same way between the Jaccard indices
comparing S2 and HMAPS and comparing S1 and S2
across field strengths to assess if there was a segmentor
bias. Intraclass correlations (ICC) were estimated on base-
line manual segmentations by S1 and S2 using the
loneway command in Stata (version 12).
To assess bias in baseline volumes we performed paired
t-tests (separately for 1.5T and 3T) comparing HMAPS
volume and the mean of S1 and S2 volumes (S1-S2-mean-
volume). We calculated the SD of pair-wise differences
between S1-S2-mean-volume and HMAPS volume sepa-
rately for 1.5T and 3T to evaluate agreement between man-
ual and automated volumes at different field strengths. We
calculated the ratio of these SDs to quantify the difference in
agreement between 1.5T and 3T volumes. Bias-corrected
and accelerated 95 % bootstrap confidence intervals
(10,000 bootstrap replicates) were calculated for the SDs
and their ratio.
Annualised atrophy rate as a percentage of baseline volume
was calculated using the BSIs on a log scale and back-
transformed. To assess bias in atrophy rates we performed t-
tests (separately for 1.5Tand 3T) comparing HMAPS atrophy
rates to the mean of rates from S1 and S2 (S1-S2-mean-BSI).
Separately for 1.5T and 3T, we calculated the SD of pair-
wise differences between S1-S2-mean-BSI and HMAPS-
BSI as a measure of agreement between atrophy rates
derived from manual and HMAPS segmentations. We also
calculated the ratio of these two SDs to quantify the
difference in agreement between 1.5T and 3T atrophy
rates. Bias-corrected and accelerated 95 % bootstrap con-
fidence intervals (10,000 bootstrap replicates) were calcu-
lated for the SDs and their ratio.
To quantify the ability of a) HMAPS volumes and b)
hippocampal BSI atrophy rates to discriminate between AD
subjects and controls, we estimated the area under the receiver
operating characteristic curve (AUC) for each measure and
used the Wilcoxon rank-sum test to test the null hypothesis
that the AUC equalled 0.5 (which corresponds to no predictive
value). We calculated 95% confidence intervals for the AUCs
and compared AUCs between measures using the Stata com-
mands roccomp and comproc.
Post Hoc Analysis
Annualised atrophy rate as mm3 loss per year was
calculated using the BSI. To assess bias in atrophy rates
we performed t-tests (separately for 1.5T and 3T) com-
paring HMAPS atrophy rates to the mean of rates from
S1 and S2 (S1-S2-mean-BSI).
Results
Baseline characteristics are shown in Table 1. The AD sub-
jects included more APOE ε4 carriers and had lower MMSE
scores than controls, as expected.
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Jaccard Indices
Means and SDs of Jaccard indices are shown in Table 2.
The difference in mean Jaccards comparing S1 and
HMAPS between 1.5T and 3T scans was small (0.003 [95 %
CI: -0.008, 0.014], p =0.56) with higher Jaccards at 3T. The
difference in mean Jaccards comparing S2 and HMAPS be-
tween 1.5T and 3T was also small with a narrow confidence
interval (0.007 [95 % CI: -0.002, 0.017], p =0.56) with higher
Jaccards at 1.5T. There was evidence that the difference in
mean Jaccards comparing S1 and S2 was higher for 3T than
1.5T scans (0.010 [95 % CI: 0.001, 0.019], p =0.02).
The inter-rater ICC (in this sample of 18 AD and 18
controls) for S1 and S2 was 0.971 (95 % CI: 0.952, 0.990)
on 1.5T scans and 0.980 (95 % CI: 0.967, 0.993) on 3T scans.
Volumes
The means and SDs of baseline volumes are shown in
Table 3.
Across all subjects, there was some evidence of a differ-
ence in volumes of S1 and S2 for 1.5T (mean difference
0.06ml [95 %CI 0.012, 0.10], p =0.015) with higher volumes
for S2. There was evidence that the HMAPS-volume was on
average 0.08ml [95%CI 0.03, 0.13, p =0.002] lower than S1-
S2-mean-volume at 1.5T. Mean volumes for S1 and S2 were
similar at 3T (mean difference 0.002 ml [95 %CI -0.04, 0.04],
p =0.92). For 3T there was evidence that HMAPS volumes
were lower than S1-S2-mean-volume (mean difference
0.13 ml [95 % CI 0.08, 0.18], p <0.001).
The SD of the difference between S1-S2-mean-volume and
HMAPS-volume was similar for 1.5Tscans (0.15 ml [95 %CI
0.13, 0.18]) and 3T scans (0.15 ml [95 % CI 0.12, 0.19]),
suggesting similar levels of agreement. The ratio of these SDs
was 0.99 [95 % CI 0.85, 1.22]. The relatively narrow confi-
dence interval for the ratio indicates moderate evidence that
agreement between manual and HMAPS volumes is similar at
1.5T and 3T.
Atrophy Rates
Table 4 shows the means and SDs for atrophy rates at 1.5Tand
3T.
Across all subjects, there was evidence that atrophy
rates from S2 were smaller than for S1 for 1.5T (mean
difference 0.29 % points [95 % CI: 0.10, 0.47], p =0.003).
There was borderline evidence of a difference between
S1-S2-mean-BSI and HMAPS-BSI for 1.5T with HMAPS
rates being higher (mean difference 0.22 % points [95 %
CI -0.01, 0.45], p =0.06). There was evidence that atrophy
rates from S2 were smaller than for S1 for 3T (mean
difference 0.15 % points [95 % CI 0.03, 0.27], p =0.01).
For 3T the difference between S1-S2-mean-BSI and
HMAPS rates was of a similar magnitude and in the same
direction as for 1.5T (mean difference 0.18 % points
[95 % CI -0.04, 0.40], p =0.10). The CI of this difference
was also similar to the CI for 1.5T atrophy rates.
The SD of the difference between S1-S2-mean-BSI and
HMAPS-BSI was similar for 1.5T scans (0.68 % points [95 %
CI 0.54, 0.89]) and 3T scans (0.65 % points [95 % CI 0.47,
0.96]), suggesting similar levels of agreement. The ratio of
these SDs was 1.04 (95 % CI 0.59, 1.41), with the wider CI
indicating that we have less confidence that is in truth similar
at 1.5T and 3T.
Because HMAPS rates were higher than manual rates in
1.5Tand 3Tand manual volumes were found to be larger than
HMAPS volumes, we repeated the atrophy rate analyses
above using mm3 loss per year as the atrophy rate measure
rather than percentage of baseline volume to lessen the influ-
ence of volume from the atrophy rate measure. These analyses
are presented in the Post hoc analysis section below.
Post Hoc Analysis
Table 5 shows the means and SDs for atrophy rates (in mm3
loss per year) at 1.5T and 3T.
Across all subjects, there was evidence that atrophy rates
from S2 were smaller than for S1 for 1.5T (mean difference
4.95 mm3 [95 % CI: 1.87, 8.03], p =0.0025). The S1-S2-
mean-BSI was similar to HMAPS-BSI for 1.5T (mean differ-
ence 2.72 mm3 [95 % CI -1.36, 6.80], p =0.18). There was
evidence that atrophy rates from S2 were smaller than for S1
for 3T (mean difference 3.64 mm3 [95 % CI 0.64, 6.64], p =
0.019). For 3T the difference between S1-S2-mean-BSI and
HMAPS rates was small (mean difference 1.62 mm3 [95 % CI
-2.40, 5.64], p =0.42).
The SD of the difference between S1-S2-mean-BSI and
HMAPS-BSI was similar for 1.5T scans (12.05 mm3 [95 % CI
9.69, 15.58]) and 3T scans (11.89 mm3 [95 % CI 8.83, 17.38]),
suggesting similar levels of agreement. The ratio of these SDs
was 1.01 (95%CI 0.64, 1.41), with the wide CI indicating again
Table 1 Baseline characteristics for controls and AD subjects. Values
represent mean (standard deviation [SD]) except for gender and APOE ε4
carrier status for which values are number (percent)
AD (n =18) Control (n =18)
Age at baseline 1.5T scan (years) 74.7 (8.1) 74.4 (4.9)
Age at baseline 3T scan (years) 74.8 (8.1) 74.5 (4.9)
1.5T scan interval (years) 1.05 (0.05) 1.07 (0.05)
3T scan interval (years) 1.01 (0.06) 1.01 (0.04)
Male 6 (33.3) 7 (38.9)
APOE ε4 carrier 11 (61.1) 7 (38.9)
MMSE (score out of 30) 23.0 (2.1) 29.4 (0.7)
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that we have less confidence that, in truth, agreement between
manual BSI rates and HMAPS BSI is similar at 1.5T and 3T.
Group Separation
Table 6 shows AUCs, 95% confidence intervals, and p -values
(testing the null hypothesis of no predictive value) for all BSI
and baseline HMAPS volumes.
Both 1.5T and 3T measures of atrophy rate and base-
line volume had high discriminative ability, although con-
fidence intervals for the AUC were wide (controls vs.
ADs). Discriminative ability was very similar using 1.5T
and 3T volumes (AUC difference 0.003 [95 % CI -0.03,
0.06]). Discriminative ability was also very similar using
1.5T and 3T atrophy rates (AUC difference 0.06 [95 % CI
-0.06, 0.19]).
Discussion
The difference in mean Jaccard index comparing the first
manual segmentor (S1) and HMAPS between 1.5T and 3T
scans was small, suggesting that HMAPS is similarly accurate
at generating volumes at both field strengths. Likewise, the
variation of the difference between manual volumes and
HMAPS volumes was similar on 1.5T and 3T scans, with a
relatively narrow CI for the ratio of SDs indicating a moderate
level of confidence that agreement is similar. Furthermore, the
differences between mean Jaccard index comparing a second
manual segmentor (S2) and HMAPS between 1.5T and 3T
scans were also small, suggesting that the accuracy of
HMAPS is not segmentor dependent. Our results are consis-
tent with Lötjönen et al. (2011) who examined differences in
hippocampal segmentations using an automated multi-atlas
segmentation method on 1.5T and 3T images and found a
high ICC of 0.98 between 1.5T and 3T segmentations. Our
data gave a comparable ICC of 0.97 between 1.5T and 3T
HMAPS segmentations.
Agreement between the volumes generated by S1 and S2
was slightly better at 3T than at 1.5T. Similarly, we found
evidence that S1 volumes were significantly lower than S2
volumes at 1.5T, but not at 3T. These findingsmay be explained
by the observation that the grey matter and white matter bound-
aries were visually clearer on the 3T scans, which would make
manual delineation easier and more consistent. Likewise,
Briellmann et al. (2001) found that manual measurement error
was slightly lower on 3T compared with 1.5T scans.
Table 2 Mean (SD) Jaccard in-
dices segmentor 1 (S1),
segmentor 2 (S2) andHMAPS for
the left hippocampus
AD (n=18) Controls (n =18) All subjects (n =36)
Jaccard indices comparing HMAPS and manual
S1 and HMAPS at 1.5T 0.806 (0.025) 0.813 (0.025) 0.810 (0.025)
S1 and HMAPS at 3T 0.817 (0.019) 0.808 (0.025) 0.813 (0.022)
S2 and HMAPS at 1.5T 0.802 (0.024) 0.812 (0.020) 0.807 (0.022)
S2 and HMAPS at 3T 0.801 (0.022) 0.798 (0.024) 0.800 (0.023)
HMAPS at 1.5T and 3T 0.825 (0.034) 0.842 (0.028) 0.833 (0.032)
Inter- and intra-segmentor Jaccard Indices
S1 and S2 at 1.5T 0.860 (0.026) 0.870 (0.029) 0.865 (0.028)
S1 and S2 at 3T 0.875 (0.029) 0.875 (0.025) 0.875 (0.027)
S1 at 1.5T and 3T 0.851 (0.030) 0.870 (0.023) 0.861 (0.028)
Table 3 Mean (SD) baseline hippocampal volumes (left side only) for
segmentor 1 (S1), segmentor 2 (S2) and HMAPS at 1.5T and 3T




Baseline volumes (ml) at 1.5T
S1 at 1.5T 2.01 (0.53) 2.68 (0.46) 2.34 (0.60)
S2 at 1.5T 2.06 (0.58) 2.74 (0.47) 2.40 (0.63)
HMAPS at 1.5T 1.95 (0.55) 2.63 (0.42) 2.23 (0.54)
Baseline volumes (ml) at 3T
S1 at 3T 2.00 (0.46) 2.71 (0.47) 2.36 (0.58)
S2 at 3T 2.01 (0.49) 2.69 (0.45) 2.35 (0.58)
HMAPS at 3T 1.91 (0.46) 2.54 (0.43) 2.23 (0.54)
Table 4 Mean (SD) hippocampal atrophy rates for segmentor 1 (S1),
segmentor 2 (S2) and HMAPS at 1.5T and 3T for the left side only
AD (n=18) Control (n =18) All subjects (n =36)
BSI (%/year) rates at 1.5T
S1 at 1.5T 3.85 (2.24) 0.08 (1.75) 1.97 (2.75)
S2 at 1.5T 3.46 (2.14) −0.10 (1.77) 1.68 (2.65)
HMAPS at 1.5T 4.03 (2.50) 0.06 (1.79) 2.05 (2.94)
BSI (%/year) rates at 3T
S1 at 3T 3.42 (2.00) 0.42 (1.86) 1.92 (2.44)
S2 at 3T 3.22 (1.92) 0.31 (1.89) 1.77 (2.39)
HMAPS at 3T 3.63 (2.49) 0.43 (1.92) 2.03 (2.73)
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We found evidence that HMAPS volumes were smaller
than manual volumes at 1.5T and 3T. Leung et al. (2010a)
report smaller automated volumes relative to manual segmen-
tation with overall mean differences (for control, MCI and AD
subjects, on 1.5T images from ADNI) of 27 mm3 and
101 mm3 for two separate groups of subjects. This is compa-
rable to the mean difference of 0.08 ml (80 mm3) for the 1.5T
images in this paper.
We found borderline evidence that HMAPS atrophy rates
(% per year) differed from rates derived from manual
segmentors at 1.5T but no evidence of a difference at 3T.
The difference between HMAPS atrophy rates and manual
segmentations at 1.5T may be driven by the lower atrophy
rates of S2. The lower atrophy rates of S2 compared with S1
and HMAPS could be due to the tendency of S2 for larger
volumes, which affects our atrophy rate measure as baseline
volume serves as a denominator for this measure. Consequent-
ly we repeated this analysis usingmm3 loss per year and found
no evidence of a difference between HMAPS and manually
derived rates at 1.5T and 3T. The variation of the difference
between manually derived rates and HMAPS atrophy rates
was similar for 1.5Tscans and 3Tscans (using both% per year
and mm3 loss per year), suggesting that agreement between
atrophy rates derived from the automated procedure with BSI
and from manual procedure with BSI is similar on 3T and
1.5T scans. However, the large confidence interval for the
ratio of SDs indicates that there is a large amount of uncer-
tainty about this finding. The implication of this uncertainty
may mean that if longitudinal studies include scans across
subjects at 1.5T and 3T it would be prudent to take this into
account in the analyses.
Finally, we found that the ability of HMAPS volumes and
atrophy rates to distinguish between control subjects and
subjects with AD was high, with AUC values between 0.83
and 0.92, with a similar level of predictive ability at 1.5T and
3T for both volumes and atrophy rates.
Strengths of this study included the multi-site nature of the
study, and having multiple field strengths at same time-points,
which allowed for comparison of field strengths. Limitations
included the small number of subjects, which limits the pre-
cision with which differences in agreement between 1.5T and
3T can be estimated. Also, 1.5T and 3T scans for the same
time-points were not always conducted on the same day,
meaning that scan intervals differed between scan pairs which
may affect measurement error. This effect was minimised by
selecting subjects with scan intervals that were less than
60 days different between 1.5T and 3T scans. Another limita-
tion is that the ADNI researchers designed the MRI protocol
such that the tissue contrast of the 3T scans closely matched
the 1.5T scans (Ho et al. 2010). This design may have con-
tributed to the similarities we found between 1.5Tand 3T. It is
also important to note that this paper only examined differ-
ences in field strength. Differences between hippocampal
volumes and atrophy rates could also be due to other factors
that were not examined in this investigation such as scanner
manufacturer or head coil. A further consideration is that it is
not known whether the performance of the ADNI image pre-
processing corrections is similar at different field strengths.
The results reported in this paper relate to a 1.5T hippo-
campal template library and its application to 1.5T and 3T
image pairs. A template library created at 1.5Twill not benefit
from the improved contrast seen at 3T and as such the results
of applying a 3T-based template library may differ to those
presented here. Further, we investigated AD-control differ-
ences as part of this study, however, techniques such as
HMAPS and associated BSIs may be most useful in detecting
pre-clinical AD. As such the application of HMAPS and BSI
to an MCI group to assess the sensitivity to conversion to AD
and whether this is influenced by field strength would be
useful.
Conclusion
We found a high level of agreement between volumes gener-
ated by an automated segmentation technique, HMAPS,
Table 5 Mean (SD) hippocampal atrophy rates (mm3 loss per year) for






BSI (mm3 loss per year) rates at 1.5T
S1 at 1.5T 76.18 (43.68) 0.03 (45.80) 38.10 (58.62)
S2 at 1.5T 70.64 (42.22) -4.33 (47.33) 33.15 (58.22)
HMAPS at 1.5T 75.68 (41.94) 1.01 (42.52) 38.35 (56.27)
BSI (mm3 loss per year) rates at 3T
S1 at 3T 65.07 (38.29) 11.57 (47.96) 38.32 (50.65)
S2 at 3T 61.82 (38.02) 7.56 (47.51) 34.69 (50.55)
HMAPS at 3T 66.04 (45.25) 10.22 (45.89) 38.13 (53.09)
Table 6 Area under the receiver operator curve (AUC) representing the
value of 12-month atrophy rate (% baseline volume) and baseline vol-
umes in discriminating between controls and AD subjects, 95 % confi-
dence intervals, and p-values testing the null hypothesis that the AUC
equals 0.5 for each of the measures
AUC 95 % confidence interval p-value
Lower Upper
1.5T HMAPS volume 0.833 0.694 0.973 0.0006
3T HMAPS volume 0.836 0.703 0.970 0.0006
1.5T HMAPS BSI 0.917 0.825 1.000 <0.0001
3T HMAPS BSI 0.861 0.742 0.980 0.0002
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relative to manual measurements on MR scans acquired at
1.5T and 3T. Further, when generating atrophy rates for both
the HMAPS and manual baseline regions using an automated
technique for quantifying volume loss (BSI), agreement be-
tween HMAPS and manual atrophy rate measures was similar
for 1.5Tand 3Tscans. However, for both volumes and atrophy
rates, the CIs for the difference in agreement between 1.5Tand
3T indicated that, in truth, differences in agreement may be
larger. HMAPS volumes and atrophy rates discriminated well
between controls and AD subjects, and there was no evidence
of a difference in predictive ability between 1.5T and 3T. This
study supports the use of HMAPS automated hippocampal
measures, developed using 1.5T images, with 3T images.
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Appendix
We defined the hippocampus as including the dentate gyrus,
the hippocampus proper, the subiculum and the alveus. Mea-
surements were taken from every coronal slice from the pos-
terior to anterior boundaries using a standard neuroanatomical
atlas (Duvernoy 1998). The posterior boundary of the hippo-
campus was defined as the coronal slice where the longest
length of the crus of the fornix was seen (Watson et al. 1992).
The hippocampus was bounded superiorly, medially and lat-
erally by CSF and inferiorly by the white matter of the
subiculum. The hippocampal head was delineated from the
amygdala by inclusion of the alveus, best seen as high signal
intensity band on sagittal sections. We applied a minimum
threshold of 70 % of mean brain intensity to improve consis-
tency by excluding voxels which were predominantly cere-
brospinal fluid.
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Commons Attribution License which permits any use, distribution, and
reproduction in any medium, provided the original author(s) and the
source are credited.
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